Donald West King, JR
Physician at Maryland Ave, Chicago, IL
License number
Colorado 14697
Issued Date
Jan 14, 1964
Renew Date
May 31, 1991
Expiration Date
May 31, 1991
Type
Physician
Address
Address
5841 S Maryland Ave BOX 417, Chicago, IL 60637
Professional information
Senior Marketing/General Management Executive
Position:
Founder and Managing Director at Nobility Ventures LLC
Location:
Greater Chicago Area
Industry:
Consumer Goods
Work:
Nobility Ventures LLC
- Greater Chicago Area since Mar 2012
-
Founder and Managing Director
Kraft Foods
- Northfield, IL Mar 2010 - Oct 2011
-
Vice-President, Retail Experience
Kraft Foods
May 2009 - Aug 2011
-
Vice-President, Marketing
The Coca-Cola Company
Dec 2004 - Apr 2009
-
Group Marketing Director
BI-LO, LLC
2003 - 2004
-
Vice-President, Marketing
Priceline WebHouse Club, Inc.
- Stamford, CT 2000 - 2000
-
Vice-President, Business Development
Procter & Gamble
- Cincinnati Area 1990 - 2000
-
Brand Management
Education:
University of Pennsylvania - The Wharton School 1988 - 1990
MBA, Marketing & Finance Stanford University 1982 - 1986
B.S., Mechanical Engineering Fairborn Park Hills High School 1978 - 1982
MBA, Marketing & Finance Stanford University 1982 - 1986
B.S., Mechanical Engineering Fairborn Park Hills High School 1978 - 1982
Cpa, Chief Information Officer &Amp; Director Of Tax At Jmg Financial Group, Ltd.
Position:
Chief Information Officer, Director of Tax at JMG Financial Group, Ltd.
Location:
Greater Chicago Area
Industry:
Financial Services
Work:
JMG Financial Group, Ltd.
since Apr 1985
-
Chief Information Officer, Director of Tax
DePaul University
1980 - 2000
-
Adjunct Associate Professor, Taxation
Arthur Young & Co
Jan 1978 - Apr 1985
-
Principal, Tax Department
Internal Revenue Service
1973 - 1978
-
Revenue Agent
Education:
DePaul University - Charles H. Kellstadt Graduate School of Business 1979
MS, Taxation Illinois Institute of Technology 1966 - 1970
BS, Mathematics
MS, Taxation Illinois Institute of Technology 1966 - 1970
BS, Mathematics
V.p. Corporate Finance At Pactiv
Position:
Corporate Controller and Chief Accounting Officer at Pactiv
Location:
Greater Chicago Area
Industry:
Packaging and Containers
Work:
Pactiv
since Feb 2000
-
Corporate Controller and Chief Accounting Officer
Education:
University of Illinois at Urbana-Champaign - College of Business 1974 - 1978
Account Manager At Netprologic Inc
Position:
Account Manager at NetProLogic, Inc
Location:
Greater Chicago Area
Industry:
Staffing and Recruiting
Work:
NetProLogic, Inc
since Sep 2008
-
Account Manager
Donald King - Chicago, IL
Education:
Coyne American Institute - Chicago, IL
Certificate in electrical construction and maintenance
Certificate in electrical construction and maintenance
Differentiation Antigen, Nda.sub.3, Associated With The Receptor For B Cell Growth Factor
US Patent:
5066581, Nov 19, 1991
Filed:
Feb 5, 1987
Appl. No.:
7/011004
Inventors:
Nicole Suciu-Foca - Cliffside Park NJ
Donald W. King - Chicago IL
Donald W. King - Chicago IL
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
C07K 1506, C07K 1528, G01N 33567, G01N 33577
US Classification:
435 724
Abstract:
This invention provides a purified new differentiation antigen, designated NDA. sub. 3, associated with the growth and proliferation of activated B lymphocytes and characterized by a molecular weight of about 36,000 daltons.
The invention also provides an antibody capable of specifically forming a complex with purified NDA. sub. 3. Another aspect of the invention provides a hybridoma which produces a monoclonal antibody that specifically recognizes the isolated NDA. sub. 3.
The invention also pertains to a method for detecting B cells or helper T cells, each of which has a B cell growth factor receptor, which comprises contacting a sample which contains B cells or helper T cells with substances capable of forming complexes with the B cell growth factor receptors so as to form cellular complexes between the substances and the B cell growth factor receptors, and detecting such cellular complexes.
Differentiation Antigen, Nda4, Associated With The Receptor For B Cell Growth Factor
US Patent:
5405750, Apr 11, 1995
Filed:
Jun 2, 1992
Appl. No.:
7/893596
Inventors:
Nicole Suciu-Foca - Cliffside Park NJ
Donald W. King - Chicago IL
Donald W. King - Chicago IL
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
C07K 1528, G01N 33577
US Classification:
435724
Abstract:
This invention provides a purified new differentiation antigen, designated NDA4, associated with the growth and proliferation of activated B lymphocytes and characterized by a molecular weight of about 46,000 daltons.
The invention also provides an antibody capable of specifically forming a complex with purified NDA4, and a hybridoma which produces a monoclonal antibody that specifically recognizes the isolated NDA4.
The invention also pertains to a method for dectecting B cells or helper T cells, each of which has a B cell growth factor receptor, which comprises contacting a sample which contains B cells or helper T cells with substances capable of forming complexes with the B cell growth factor receptors so as to form cellular complexes between the substances and the B cell growth factor receptors, and detecting such cellular complexes.
Late Differentiation Antigen Associated With Helper T Lymphocyte Function
US Patent:
4818689, Apr 4, 1989
Filed:
Jul 5, 1985
Appl. No.:
6/752397
Inventors:
Nicole Suciu-Foca - Cliffside Park NJ
Donald W. King - Chicago IL
Donald W. King - Chicago IL
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
G01N 3353
US Classification:
435 7
Abstract:
A late differentiation antigen (LDA. sub. 1) expressed by activated helper cells is described. LDA. sub. 1 is a membrane protein recognized by a monoclonal antibody produced by immunizing mice with an alloreactive human T cell clone with helper function. LDA. sub. 1 is expressed by helper T cells optionally 9 days after activation. Anti-LDA. sub. 1 monoclonal antibody blocks T cell enhancement of B-cell immunoglobulin production. Thus, LDA. sub. 1 is associated with helper T cell effector function. Methods of diagnosis and therapy based upon LDA. sub. 1 are also described.
Late Differentiation Antigens Associated With Helper T Lymphocyte Function
US Patent:
4816404, Mar 28, 1989
Filed:
Feb 18, 1986
Appl. No.:
6/830697
Inventors:
Nicole Suciu-Foca - Cliffside Park NJ
Donald W. King - Chicago IL
Donald W. King - Chicago IL
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
C12N 500, C07K 1504
US Classification:
43524027
Abstract:
Late differentiation antigens (LDA. sub. 1 and LDA. sub. 2) expressed by activated helper cells are described. LDA. sub. 1 and LDA. sub. 2 are membrane proteins recognized by monoclonal antibodies produced by immunizing mice with alloreactive human T cell clones with helper function. LDA. sub. 1 and LDA. sub. 2 are expressed by helper T cells. LDA. sub. 1 monoclonal antibody and LDA. sub. 2 monoclonal antibody block T cell enhancement of B cell immunoglobulin production. Thus, LDA. sub. 1 and LDA. sub. 2 are associated with helper T cell effector function. Methods of diagnosis and therepy based upon LDA. sub. 1 and LDA. sub. 2 are also described.